ESR1 and triple-negative breast carcinoma: Importantly, approximately 15% of all breast cancers do not express estrogen receptor (ER), progesterone receptor (PR), or human epidermal growth factor receptor 2 (HER-2); this type is referred to as triple-negative breast cancer (TNBC).